DICOPAC KIT
LOE ApproachingNDAN/AN/A
Approved
Jun 1974
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 4d ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
DICOPAC KIT is a diagnostic imaging kit manufactured by GE HealthCare, approved in 1974 as an NDA product. The product's specific mechanism of action and therapeutic indications are not publicly detailed, but it functions within diagnostic imaging workflows. It represents a legacy radiopharmaceutical or imaging agent from GE's portfolio.
LOE Approaching
This is a legacy product nearing or at loss of exclusivity, likely managed by a small, specialized team focused on transition planning rather than growth.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on DICOPAC KIT offers limited career growth due to its LOE-approaching status and zero linked job openings. Roles are typically in support, compliance, and continuity rather than commercial launch or expansion, making this a niche career opportunity suited to specialists in legacy product management.
Supply Chain ManagerMedical Affairs Specialist
Worked on DICOPAC KIT at GE HealthCare? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.